コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n, although E2 is predicted to be a class II viral fusion protein.
2 ible and did not lead to inactivation of the viral fusion protein.
3 ks any of the defining features of a typical viral fusion protein.
4 ein, while gH/gL does not resemble any known viral fusion protein.
5 H/gL has no structural homology to any known viral fusion protein.
6 r epitope-specific responses compared to the viral fusion protein.
7 the viral spike (S) glycoprotein, a class I viral fusion protein.
8 RS-CoV viral spike glycoprotein is a class I viral fusion protein.
9 iniscent of the conformational transition of viral fusion proteins.
10 sponsible for proteolytic activation of many viral fusion proteins.
11 roposed for the fusion mechanisms of class I viral fusion proteins.
12 le similar to the proposed fusogenic core of viral fusion proteins.
13 g domain is not critical for the activity of viral fusion proteins.
14 he mechanism of fusion promoted by these two viral fusion proteins.
15 entiates them from many other low-pH-induced viral fusion proteins.
16 cule inhibitors of both class I and class II viral fusion proteins.
17 ign concepts can be applied to other Class 1 viral fusion proteins.
18 lambda spanins, which are similar to class I viral fusion proteins.
19 and an evolutionary connection between these viral fusion proteins.
20 g blocks of the unilaterally acting class-II viral fusion proteins.
21 oteins and falls into the group of class III viral fusion proteins.
22 consistent with the requirement for TMRs in viral fusion proteins.
23 oped viruses proceeds through the actions of viral fusion proteins.
24 k domains may be a common feature of class I viral fusion proteins.
25 le fusogenic conformational changes in other viral fusion proteins.
26 onmental pH that can trigger the activity of viral fusion proteins.
27 ons of which extend to BNAb targets on other viral fusion proteins.
28 a founder member of the class III family of viral fusion proteins.
29 tions mediated by their structurally similar viral fusion proteins.
30 ils like those in cellular SNAREs or in some viral fusion proteins.
31 precedented glimpses into the interaction of viral fusion proteins and membranes, revealing fusion in
32 fy initial strategies to stabilize class III viral fusion proteins and provide tools to probe gB-dire
35 ry that assembles between cells includes the viral fusion proteins and various accessory proteins tha
36 protein that is very large compared to other viral fusion proteins, and all except a short carboxy-te
37 idate for structural studies of the class II viral fusion proteins, and we report conditions that gen
38 ediated by influenza hemagglutinin and other viral fusion proteins apparently involve local lipidic c
45 ished data showed that both peripherin-2 and viral fusion proteins are transmembrane proteins that pr
50 epeat regions (HR1 and HR2, respectively) of viral fusion proteins can block infection of viruses in
51 dies have shown that the membrane anchors of viral fusion proteins can form highly specific oligomers
54 n residues can affect folding or function of viral fusion proteins, direct analysis of TM-TM interact
55 ion and postfusion crystal structures of the viral fusion protein E1 in conjunction with biochemical
56 lls expressing the low pH-triggered class II viral fusion protein E1 of Semliki Forest virus (SFV) we
58 are useful tools to study the properties of viral fusion proteins, especially those from highly path
61 earing a single amino acid alteration in the viral fusion protein (F; L454W) was previously identifie
64 membranes.Crystal structures for a number of viral fusion proteins facilitating this process have con
65 on peptide and transmembrane domains of many viral fusion proteins form stable helical bundles and in
66 HIV-1 gp41, providing further evidence that viral fusion proteins from diverse families such as Orth
76 ture, VSV G has been classified as class III viral fusion protein, having a predicted bipartite fusio
77 ruses utilize host proteases to activate the viral fusion protein, hemagglutinin (HA), into its fusio
79 have shown that GPC is unique among class I viral fusion proteins in that the mature complex retains
80 ith the structures observed for other type 1 viral fusion proteins in their fusion-competent state.
82 shares the characteristics of FPs of class I viral fusion proteins, including high Ala/Gly content, i
83 with functionally analogous regions of other viral fusion proteins, including the presence and distri
84 against other enveloped viruses with class I viral fusion proteins, indicating specificity for arenav
85 organisation of glycosylation across class I viral fusion proteins influence not only individual glyc
87 authors show that a chemical inhibitor to a viral fusion protein is effective in reducing viral titr
88 ovirus and lentivirus vectors with different viral fusion proteins is a useful strategy to alter the
89 present at the N-terminal region of class I viral fusion proteins is believed to initiate viral and
92 monstrated similarities between gB and other viral fusion proteins, leading to the hypothesis that gB
93 e trimer-of-hairpins conformation of class I viral fusion proteins, less is known about intermediate
94 and exposed to low pH, indicating that this viral fusion protein may function in a manner unique amo
95 Thus, Gly residues in the TM domain of other viral fusion proteins may also prove to be important for
97 ng hMPV is the fusion (F) protein, a class I viral fusion protein mediating virus-cell membrane fusio
98 ke previous observations for several class I viral fusion proteins, mice immunized with postfusion or
101 ng genetic engineering approaches to express viral fusion proteins on the surface of cell membrane-co
102 on models developed from numerous studies of viral fusion proteins, our results indicate that these a
106 a host cell is mediated by spike, a class I viral fusion protein responsible for merging the viral a
108 identified structural relationships between viral fusion proteins shift the paradigm for how these p
109 now extends this description to "class III" viral fusion proteins, showing that reversibility of the
110 n of TM-TM interactions significantly impact viral fusion protein stability and function, presenting
111 The C-terminal transmembrane domain (TMD) of viral fusion proteins such as HIV gp41 and influenza hem
112 n proteins distinguish them from the class I viral fusion proteins, such as influenza virus hemagglut
114 = 0.004) more abundant in the TM domains of viral fusion proteins than in those of nonfusion protein
115 ARS-CoV) spike glycoprotein (S) is a class I viral fusion protein that binds to its receptor glycopro
117 executed by glycoprotein B (gB), a class III viral fusion protein that is conserved across all herpes
119 nucleopolyhedrovirus (AcMNPV) is a class III viral fusion protein that mediates pH-triggered membrane
120 tides are short N-terminal regions of type-1 viral fusion proteins that are critical for virus entry.
121 hat of postfusion gB, unlike certain class I viral fusion proteins that have been used as vaccine ant
129 e that AVP-p induces premature activation of viral fusion proteins through membrane perturbance.
130 demonstrate for the first time that class I viral fusion protein TM domains can self-associate as tr
132 e receptor-binding molecule must trigger the viral fusion protein to mediate fusion and entry of the
133 with CoV and LP IAV pseudoparticles, cleaved viral fusion proteins to fusion-primed fragments and pot
134 nctions, including endogenous neuropeptides, viral fusion proteins, topogenic peptides, and amyloids.
135 initiated by a conformational change in the viral fusion protein, triggered by receptor binding, an
142 een widely assumed that HCV E2 is a class II viral fusion protein (VFP), the newly determined structu
143 the membrane fusion activity of heterologous viral fusion proteins when GS is coexpressed with those
145 or part of the membrane-spanning domain of a viral fusion protein with sequences that encode signals
147 data suggest a novel priming mechanism for a viral fusion protein, with a critical proteolytic cleava
148 ich is structurally categorized as a class I viral fusion protein, within the same group as influenza